Evidence map›Paper›PMID 42494868›Full record

ArticleFrontiers in endocrinology2026

Cardiomyopathy in women with acromegaly: clinical characteristics and associated factors in a Colombian multicenter registry.

Santiago Sierra-Castillo, David Aristizabal-Colorado, Andres Arteaga-Arellano, Daniel Miranda-Brazales, Ysamar Aquino, Juan Andres Muñoz-Ordoñez, Daniel Sierra-Castillo, Juan C Peláez Ortiz, David Alexander Vernaza Trujillo, Juan S Izquierdo-Condoy and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Santiago Sierra-CastilloDepartment of Epidemiology, CES University, Medellín, Colombia.
David Aristizabal-ColoradoDepartment of Cardiology, University of Antioquia, Medellín, Colombia.
Andres Arteaga-ArellanoDepartment of Internal Medicine, Impulso, Quito, Ecuador.
Daniel Miranda-BrazalesDepartment of Internal Medicine, International University of Ecuador, Quito, Ecuador.
Ysamar AquinoDepartment of Cardiology, Universidad Abierta Interamericana (UAI), Buenos Aires, Argentina.
Juan Andres Muñoz-OrdoñezFaculty of Health Sciences, Icesi University, Cali, Colombia.
Daniel Sierra-CastilloFaculty of Health Sciences, Universidad Pontificia Bolivariana, Medellín, Colombia.
Juan C Peláez OrtizFaculty of Health Sciences, Universidad Pontificia Bolivariana, Medellín, Colombia.
David Alexander Vernaza TrujilloDepartment of Public Health, Pontificia Universidad Javeriana Cali, Cali, Colombia.
Juan S Izquierdo-CondoyOne Health Research Group, Universidad de las Américas, Quito, Ecuador.
Clara SaldarriagaDepartment of Cardiology, University of Antioquia, Medellín, Colombia.
Alin Abreu-LombaGrupo interinstitucional de medicina interna (GIMI 1), Universidad Libre, Cali, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acromegalic heart disease (AHD) is a common complication of acromegaly; however, evidence specifically focused on women in Latin America remains limited. Objective: To characterize cardiomyopathy in women with acromegaly and identify clinical factors associated with its presence. Methods: We conducted a secondary analysis of the multicenter RAPACO-Heart registry in Colombia. Women aged ≥18 years with confirmed acromegaly and available echocardiographic evaluation were included. Clinical, anthropometric, biochemical, and echocardiographic data were analyzed. Cardiomyopathy was defined by echocardiographic abnormalities consistent with AHD. Multivariable logistic regression was used to identify factors independently associated with cardiomyopathy. Results: A total of 116 women were included, of whom 34 (29.3%) had cardiomyopathy. Women with cardiomyopathy were older and had longer disease duration. Hypertension, arrhythmias, and carpal tunnel syndrome were more frequent in this group. In multivariable analysis, age (adjusted OR 1.07 per year; 95% CI 1.03-1.12; p = 0.001), hypertension (adjusted OR 3.9; 95% CI 1.4-11.1; p = 0.009), arrhythmias (adjusted OR 2.8; 95% CI 1.1-7.4; p = 0.03), and carpal tunnel syndrome (adjusted OR 2.6; 95% CI 1.1-6.5; p = 0.04) were independently associated with cardiomyopathy. Conclusions: Cardiomyopathy was present in nearly one-third of women with acromegaly and was associated with older age and a higher burden of cardiovascular comorbidities. These findings highlight an underrecognized cardiovascular burden and support targeted cardiovascular assessment in this population.

Indexed as

AcromegalyCardiomyopathiesAdultAgedColombiaEchocardiographyFemaleHumansMiddle AgedRegistriesRisk Factorsacromegalic heart diseaseacromegalycardiomyopathygrowth hormoneheart diseasesIGF-1women

Identifiers

PMID42494868
PMCPMC13391256

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.